BCNC involved in the external review of the latest edition of Prodigy guidance for Benzodiazepines / Z drugs

BCNC, through one of its' founder members, has been involved in the external review of the latest edition of PRODIGY guidance for Benzodiazepines / Z drugs - withdrawing treatment and the associated Patient Information Leaflets (PILs) namely Benzodiazepines and Z drugs and Stopping Long-term Benzodiazepines. PRODIGY guidance and PILs are freely accessible from the PRODIGY website www.prodigy.nhs.uk. The PILs are also available from the Patient UK website.

PRODIGY guidance is developed by clinicians and pharmacists for healthcare professionals, and this works well with the BCNC policy of working with all aspects of health services to help improve the service being given in the area of prescription benzodiazepines. PRODIGY guidance and BCNC are in agreement that new patients should not be given prescription benzodiazepines for a longer period than 2/4 weeks and that withdrawal advice should be available to all existing patients who have become dependent on benzodiazepines and wish to undertake a withdrawal programme.

This statement has been agreed between BCNC and prodigy.nhs.uk

Copyright © 2006 bcnc.org.uk Organisation

Forum

Disclaimer

SiteMap

Home

Contact us

The Ashton Manual